You are Trying to View a Free Article

Daily News You Can't Find Anywhere Else

Thermo Fisher to Acquire Brammer Bio, an Industrial Info Market Brief


Industry Segment: Market Brief | Word Count: 118 Words

Off the heels of purchasing Patheon in 2017, Thermo Fisher is acquiring Brammer Bio, a viral vector contract development and manufacturing organization (CDMO) for gene therapy innovators, for $1.7 billion.

Subscribe Now! All Fields Required...

Standard Membership - Free